Shanghai Medicilon Inc. (688202.SH): The price of experimental monkeys has stabilized recently.

Shanghai Medicilon Inc. (688202.SH) recently stated during an institutional investor conference that the price of experimental monkeys has stabilized in recent times. The company has actively adopted various measures such as enriching procurement channels, deepening cooperation with experimental animal suppliers, etc. to ensure the company's experimental animals, especially the stable supply of experimental monkeys, can meet the needs of the company's operations.

Gelonghui FinanceJul 22 19:56 ET

Shanghai Medicilon Inc. (688202.SH): has put into use a total of more than 0.085 million square meters of R&D office space.

Medicilon (688202.SH) recently stated during a meeting with institutional investors that the company has invested in a total of more than 0.085 million square meters of research and development office space, located in Shanghai Zhangjiang Hi-Tech Park Development, Chuansha Economic Park, Nanhui Medicilon New Drug Innovation Center, Hangzhou Xiaoshan District, and a research and development center in Boston, USA. The main structure of the raised funds project "Drug Discovery and Pharmaceutical Research and Declaration Platform Laboratory Expansion Project" has been fully capped and has been applied for acceptance, and the "Medicilon North Shanghai Biomedical Research and Development Innovation Industry Base Project" has also officially started construction. In the future, it will be in accordance with the company's strategy.

Gelonghui FinanceJul 15 19:49 ET

Shanghai Medicilon Inc. (688202.SH): Currently, the research and development laboratory in Boston, USA has been put into use.

Shanghai Medicilon Inc. (688202.SH) recently stated during a reception with institutional investors that the company's overseas business development and production operations are actively and orderly underway. The company will lay out in multiple core overseas regions, strengthen the construction of its business team, increase communication between its overseas BD and domestic research teams, and gradually establish a market sales system adapted to overseas market competition. In addition, the company will actively participate in overseas industry conferences and increase the frequency of regular expansion of its research team. Currently, the company has put into use a research and development laboratory in Boston, USA, covering chemical, biological, and animal experiments.

Gelonghui FinanceJul 15 19:48 ET

Shanghai Medicilon Inc. (688202.SH) has repurchased 0.1917% of its shares.

On July 1st, Gelonhui reported that Shanghai Medicilon Inc. (688202.SH) has repurchased a total of 258,153 shares through the Shanghai Stock Exchange centralized bidding trading system as of June 30, 2024. The repurchased shares account for 0.1917% of the company's total share capital. The highest repurchase transaction price is 32.55 yuan/share, the lowest is 26.44 yuan/share, and the total amount paid is 7,450,315.99 yuan (excluding stamp duty, transaction fees, and other expenses).

Gelonghui FinanceJul 1 05:21 ET

Shanghai medicilon inc. (688202.SH): has repurchased 26,400 shares of company stock.

On June 4th, Gelonhui reported that Shanghai Medicilon Inc. (688202.SH) has cumulatively repurchased 26,353 shares of the company's stock through the Shanghai Stock Exchange auction trading system as of May 31, 2024, accounting for 0.0196% of the total outstanding shares. The highest and lowest repurchase prices were 32.55 yuan/share and 32.44 yuan/share, respectively. The total amount paid was RMB 857,100.20 (excluding stamp duty, transaction fees, and other expenses).

Gelonghui FinanceJun 4 05:30 ET

Medici (688202.SH): Initial repurchase of 26,353 shares

Gelonghui (688202.SH) announced on May 30, 2024, that on May 30, 2024, the company repurchased 26,353 shares for the first time through centralized bidding. The repurchased shares accounted for 0.0196% of the company's total share capital, the highest transaction price was 32.55 yuan/share, the minimum transaction price was 32.44 yuan/share, and the total transaction amount was 857,100.20 yuan (excluding transaction fees such as stamp duty and transaction commissions).

Gelonghui FinanceMay 30 05:54 ET